Related Experiment Video

Updated: Aug 15, 2026

Event-related Potentials During Target-response Tasks to Study Cognitive Processes of Upper Limb Use in Children with Unilateral Cerebral Palsy
08:26

Event-related Potentials During Target-response Tasks to Study Cognitive Processes of Upper Limb Use in Children with Unilateral Cerebral Palsy

Published on: January 11, 2016

Botulinum toxin and cerebral palsy: time for reflection?

M Gough1, C Fairhurst, A P Shortland

  • 1One Small Step Gait Analysis Laboratory, Guy's Hospital, London, UK. martin.gough@gstt.sthames.nhs.uk

Developmental Medicine and Child Neurology
|September 22, 2005
PubMed

Insights

Early botulinum toxin A (BTX-A) injections for cerebral palsy (CP) spasticity may improve short-term function but lack long-term outcome data. A cautious approach is advised until more evidence is available.

Area of Science:

  • Pediatric Neurology
  • Rehabilitation Medicine
  • Biologics and Drug Therapy

Background:

  • Botulinum toxin A (BTX-A) is increasingly used for early spasticity management in ambulant children with cerebral palsy (CP).
  • Aims include improving function, promoting muscle growth, and delaying surgery.
  • Limited evidence exists regarding the long-term outcomes of BTX-A injections in this population.

Purpose of the Study:

  • To evaluate the long-term effects of early BTX-A injections on function and muscle growth in children with CP.
  • To address concerns about potential adverse long-term effects on muscle function.
  • To inform clinical practice regarding the cautious use of BTX-A.

Main Methods:

  • Review of existing literature on BTX-A use in pediatric CP.
  • Analysis of functional outcomes and muscle growth data.
  • Consideration of spasticity versus muscle weakness in management strategies.

Main Results:

  • BTX-A may offer short-term functional improvements in spasticity.
  • Potential for adverse long-term effects on muscle growth and function exists.
  • Current evidence on long-term outcomes remains insufficient.

Conclusions:

  • A cautious approach to early BTX-A use is recommended for ambulant children with spastic diplegic CP.
  • Objective outcome measures in multidisciplinary settings are crucial.
  • Further research on long-term outcomes is necessary before widespread early adoption.

More Related Videos

Abdominal Massage to Improve Motor Dysfunction in Rats with Cerebral Palsy08:24

Abdominal Massage to Improve Motor Dysfunction in Rats with Cerebral Palsy

Published on: August 11, 2023

Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations05:04

Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations

Published on: February 2, 2024

Related Concept Videos

Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Tetanus01:29

Tetanus

Tetanus is a life-threatening neurological disorder characterized by persistent muscle contractions and spastic paralysis. It is caused by Clostridium tetani, a motile, Gram-positive, rod-shaped, obligate anaerobe. These bacteria produce terminal endospores, giving them a distinctive “lollipop” or “tennis-racket” appearance. They thrive in anaerobic environments, such as those found in deep puncture wounds.Once introduced into the body, the spores germinate into vegetative cells. These cells...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...